Brief: Astal Laboratories Signed Letter Of Intent With Immuna Therapeutics GMBH
29/12/2025 14:20
Dec 29 (Reuters) - Astal Laboratories Ltd ASTB.BO: SIGNED LETTER OF INTENT WITH IMMUNA THERAPEUTICS GMBH COLLABORATION INCLUDES TECHNOLOGY TRANSFER AND LOCALIZATION IN INDIA IMMUNA COLLABORATION EXPECTED TO GENERATE 3 BILLION RUPEES REVENUE Source text: ID:nBSE7LXxl5 Further company coverage: ASTB.BO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astal Laboratories
See all newsBrief: Astal Laboratories June-Quarter Consol Profit 94.2 Million Rupees
Brief: Astal Laboratories Signed Letter Of Intent With Immuna Therapeutics GMBH
India's Astal Laboratories gains after securing European Union export compliance
Brief: Astal Laboratories To Buy 100% Of Sriven Pharmachem
Brief: Astal Laboratories Buys Pharmaceutical Intermediates Manufacturing Plant Of Shree Venus Health Sciences